Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Laura Christine Collins, M.D.

TitleAssociate Professor of Pathology
InstitutionBeth Israel Deaconess Medical Center
DepartmentPathology
AddressBeth Israel Deaconess Med Ctr
Pathology
330 Brookline Ave
Boston MA 02215
Phone617/667-4344
Fax617/667-7120

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, Connolly JL, Chen WY, Willett WC, Tamimi RM. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst. 2013 Oct 16; 105(20):1571-8.
    View in: PubMed
  2. Jeselsohn RM, Werner L, Regan MM, Fatima A, Gilmore L, Collins LC, Beck AH, Bailey ST, He HH, Buchwalter G, Brown M, Iglehart JD, Richardson A, Come SE. Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response. PLoS One. 2013; 8(5):e64225.
    View in: PubMed
  3. Collins LC, Achacoso N, Haque R, Nekhlyudov L, Fletcher SW, Quesenberry CP, Schnitt SJ, Habel LA. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat. 2013 Jun; 139(2):453-60.
    View in: PubMed
  4. Aroner SA, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Rosner BA, Hankinson SE, Tamimi RM. Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies. Breast Cancer Res Treat. 2013 May; 139(1):277-85.
    View in: PubMed
  5. Kaplan JS, Schnitt SJ, Collins LC, Wang Y, Garber JE, Montgomery K, West RB, Krag K, Fetten K, Lincoln A, Tung NM. Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers. Am J Surg Pathol. 2012 Oct; 36(10):1483-8.
    View in: PubMed
  6. Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE. Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol. 2012 Oct 1; 30(28):3468-77.
    View in: PubMed
  7. Hurchla MA, Garcia-Gomez A, Hornick MC, Ocio EM, Li A, Blanco JF, Collins L, Kirk CJ, Piwnica-Worms D, Vij R, Tomasson MH, Pandiella A, San Miguel JF, Garayoa M, Weilbaecher KN. The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects. Leukemia. 2013 Feb; 27(2):430-40.
    View in: PubMed
  8. Su X, Colditz GA, Collins LC, Baer HJ, Sampson LA, Willett WC, Berkey CS, Schnitt SJ, Connolly JL, Rosner BA, Tamimi RM. Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat. 2012 Jul; 134(2):783-91.
    View in: PubMed
  9. Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Colditz GA. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 2012 May; 129(5):e1192-8.
    View in: PubMed
  10. Nekhlyudov L, Habel LA, Achacoso N, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SW. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst. 2012 Apr 18; 104(8):614-21.
    View in: PubMed
  11. Rice MS, Tamimi RM, Connolly JL, Collins LC, Shen D, Pollak MN, Rosner B, Hankinson SE, Tworoger SS. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II. Breast Cancer Res. 2012; 14(2):R44.
    View in: PubMed
  12. Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012 Feb; 131(3):1061-6.
    View in: PubMed
  13. Santagata S, Hu R, Lin NU, Mendillo ML, Collins LC, Hankinson SE, Schnitt SJ, Whitesell L, Tamimi RM, Lindquist S, Ince TA. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A. 2011 Nov 8; 108(45):18378-83.
    View in: PubMed
  14. Pantanowitz L, Valenstein PN, Evans AJ, Kaplan KJ, Pfeifer JD, Wilbur DC, Collins LC, Colgan TJ. Review of the current state of whole slide imaging in pathology. J Pathol Inform. 2011; 2:36.
    View in: PubMed
  15. Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, Marotti J, Connolly JL, Schnitt SJ, Collins LC. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(1):159-67.
    View in: PubMed
  16. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011 Aug 3; 103(15):1179-89.
    View in: PubMed
  17. Jung MM, Colditz GA, Collins LC, Schnitt SJ, Connolly JL, Tamimi RM. Lifetime physical activity and the incidence of proliferative benign breast disease. Cancer Causes Control. 2011 Sep; 22(9):1297-305.
    View in: PubMed
  18. Holmes MD, Chen WY, Schnitt SJ, Collins L, Colditz GA, Hankinson SE, Tamimi RM. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011 Nov; 130(2):657-62.
    View in: PubMed
  19. Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study. Mod Pathol. 2011 Jul; 24(7):924-31.
    View in: PubMed
  20. Liu Y, Tamimi RM, Collins LC, Schnitt SJ, Gilmore HL, Connolly JL, Colditz GA. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. Breast Cancer Res Treat. 2011 Aug; 129(1):175-84.
    View in: PubMed
  21. Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA, Tamimi RM. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res. 2011 Apr 1; 17(7):1867-74.
    View in: PubMed
  22. Tamimi RM, Colditz GA, Wang Y, Collins LC, Hu R, Rosner B, Irie HY, Connolly JL, Schnitt SJ. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat. 2011 Jul; 128(1):243-50.
    View in: PubMed
  23. Alexander BM, Sprott K, Farrow DA, Wang X, D'Andrea AD, Schnitt SJ, Collins LC, Weaver DT, Garber JE. DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin Cancer Res. 2010 Dec 1; 16(23):5796-804.
    View in: PubMed
  24. Tung N, Miron A, Schnitt SJ, Gautam S, Fetten K, Kaplan J, Yassin Y, Buraimoh A, Kim JY, Szász AM, Tian R, Wang ZC, Collins LC, Brock J, Krag K, Legare RD, Sgroi D, Ryan PD, Silver DP, Garber JE, Richardson AL. Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers. Breast Cancer Res. 2010; 12(6):R95.
    View in: PubMed
  25. Dawood S, Hu R, Homes MD, Collins LC, Schnitt SJ, Connolly J, Colditz GA, Tamimi RM. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat. 2011 Feb; 126(1):185-92.
    View in: PubMed
  26. Aroner SA, Collins LC, Schnitt SJ, Connolly JL, Colditz GA, Tamimi RM. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res. 2010; 12(4):R61.
    View in: PubMed
  27. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast. Am J Surg Pathol. 2010 Jun; 34(6):896-900.
    View in: PubMed
  28. Haque R, Achacoso NS, Fletcher SW, Nekhlyudov L, Collins LC, Schnitt SJ, Quesenberry CP, Habel LA. Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care. 2010 May; 16(5):351-60.
    View in: PubMed
  29. Su X, Tamimi RM, Collins LC, Baer HJ, Cho E, Sampson L, Willett WC, Schnitt SJ, Connolly JL, Rosner BA, Colditz GA. Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease. Cancer Causes Control. 2010 Jul; 21(7):1033-46.
    View in: PubMed
  30. Tung N, Wang Y, Collins LC, Kaplan J, Li H, Gelman R, Comander AH, Gallagher B, Fetten K, Krag K, Stoeckert KA, Legare RD, Sgroi D, Ryan PD, Garber JE, Schnitt SJ. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Res. 2010; 12(1):R12.
    View in: PubMed
  31. Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B, Tamimi RM. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer. 2010 Jan 1; 126(1):180-90.
    View in: PubMed
  32. Collins LC, Achacoso N, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Puligandla B, Alshak NS, Goldstein LC, Gown AM, Schnitt SJ, Habel LA. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8.
    View in: PubMed
  33. Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85.
    View in: PubMed
  34. Marotti JD, Collins LC, Hu R, Tamimi RM. Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study. Mod Pathol. 2010 Feb; 23(2):197-204.
    View in: PubMed
  35. Collins LC, Wang Y, Connolly JL, Baer HJ, Hu R, Schnitt SJ, Colditz GA, Tamimi RM. Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue. Appl Immunohistochem Mol Morphol. 2009 Oct; 17(5):438-41.
    View in: PubMed
  36. Johnson NB, Collins LC. Update on percutaneous needle biopsy of nonmalignant breast lesions. Adv Anat Pathol. 2009 Jul; 16(4):183-95.
    View in: PubMed
  37. Collins LC, Martyniak A, Kandel MJ, Stadler ZK, Masciari S, Miron A, Richardson AL, Schnitt SJ, Garber JE. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers. Am J Surg Pathol. 2009 Jul; 33(7):1093-7.
    View in: PubMed
  38. Schnitt SJ and Collins LC. Pathology of Benign Breast Disorders. Diseases of the Breast. 2009; 69-85.
  39. Nekhlyudov L, Habel LA, Achacoso NS, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SW. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 Jul 1; 27(19):3211-6.
    View in: PubMed
  40. Baer HJ, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer. 2009 Apr 1; 115(7):1404-11.
    View in: PubMed
  41. Collins L, Schnitt S, Achacoso N, Fletcher S, Nekhlyudov L, Haque R, Quesenberry C and Habel L. Outcome of women with ductal carcinoma in situ (DCIS) treated with breast conserving surgery alone: a case-control study of 225 patients from the Cancer Research Network. Mod Pathol. 2009.
  42. Hu R, Dawood S, Collins LC, Schnitt SJ, Cole K, Marotti J, Colditz GA, Tamimi RM. Androgen receptor and breast cancer survival in postmenopausal women. Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2009.
  43. Cole K, Tamimi R, Hu R, Colditz G, Schnitt S and Collins. Relationship Between Molecular Phenotype Of Invasive Breast Cancer And Expression Of Androgen Receptor. Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2009.
  44. Cole K, Tamimi R, Hu R, Colditz G, Schnitt S and Collins. Relationship Between Molecular Phenotype Of Invasive Breast Cancer And Expression Of Androgen Receptor. Mod Pathol. 2009.
  45. Belsley NA, Collins LC, Rice MS, Walker S, Tworoger S and Frank DA. Expression of phospho(p)STAT3 and phospho(p)STAT5 in Breast Cancer and Correlation with Plasma Prolactin Levels. Mod Pathol. 2009.
  46. Cole K, Tamimi R, Hu R, Colditz G, Schnitt S and Collins. Androgen Receptor (AR) Expression In Ductal Carcinoma In Situ (DCIS) And Its Relationship To Molecular Subtype. Mod Pathol. 2009.
  47. Cole K, Tamimi R, Hu R, Colditz G, Schnitt S and Collins. Androgen Receptor (AR) Expression In Ductal Carcinoma In Situ (DCIS) And Its Relationship To Molecular Subtype. Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2009.
  48. Wang Y, Connolly J, Hu R, Baer H, Colditz G, Schnitt S, Collins L and Tamimi R. Expression of Insulin-Like Growth Factor-I Receptor (IGF-IR) in Normal Breast Tissue and Breast Cancer Risk: Results from the Nurses Health Study. Mod Pathol. 2009.
  49. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications. Am J Surg Pathol. 2009 Feb; 33(2):227-32.
    View in: PubMed
  50. Laura Collins, Editor. Surgical Pathology Clinics. Breast Pathology. 2008; In press.
  51. Tamimi RM, Schnitt SJ, Colditz GA, Collins LC. Luminal B breast tumors are not HER2 positive - authors' response. Breast Cancer Res. 2008; 10(5):405.
  52. SJ Schnitt and LC Collins. Breast Biopsy Interpretation. 2008.
  53. Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, Yao J, Kraeft SK, Collins LC, Sabel MS, Argani P, Gelman R, Schnitt SJ, Krop IE, Polyak K. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res. 2008 Sep 1; 14(17):5357-67.
    View in: PubMed
  54. Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008; 10(4):R67.
    View in: PubMed
  55. Alexander B, Sprott K, Weaver D, D’Andrea A, Schnitt S, Collins L, Garber J. DNA Repair Antibodies as Predictive and Prognostic Biomarkers in Triple Negative Breast Cancer. Presented at the 5th Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2008.
  56. Wang Y, Collins L, Schnitt S, Garber J and Tung N. Characterization of Estrogen Receptor Positive Breast Cancers in BRCA1 Mutation Carriers. Presented at the 5th Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2008.
  57. Collins LC, Marotti JD, Baer HJ, Tamimi RM. Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst. 2008 Feb 6; 100(3):218-21.
    View in: PubMed
  58. Gilmore HL, Collins LC, Connolly JL, Schnitt SJ. Impact of the New American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Guidelines on the Determination of Breast Cancer HER2 Status . Mod Pathol. 2008.
  59. Turner MS, Wang HH, Beasley MB, Collins LC, Folpe AL, Hecht JL, Hunt JL, van de Rijn M, Goldsmith JD. Non-Gastrointestinal Pathologists Are Highly Reproducible in Their Diagnosis of Serrated Polyps of the Colorectum Following Tutorial Instruction . Mod Pathol. 2008.
  60. Baer H, Collins L, Connolly J, Colditz G, Schnitt S, Tamimi R. Lobular Involution and Subsequent Breast Cancer Risk: Findings from the Nurses Health Studies. Mod Pathol. 2008.
  61. Hilson JB, Schnitt SJ, Collins LC. Phenotypic Profile of Myoepithelial Cells (MEC) in Benign Sclerosing Lesions and Ductal Carcinoma In Situ (DCIS: Diagnostic Implications . Mod Pathol. 2008.
  62. Espinosa I, Collins LC, West RB, Schnitt SJ, van de Rijn M. Periostin (POSTN, OSF2) Expression in Stroma of Normal Breast Tissue and Pre-Invasive Breast Lesions . Mod Pathol. 2008.
  63. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008 Jan; 52(1):20-9.
    View in: PubMed
  64. Wang Y, Collins L, Schnitt S, Garber J, Tung N. Characterization of Estrogen Receptor Positive Breast Cancers in BRCA1 Mutation Carriers . Mod Pathol. 2008.
  65. Marotti J, Tamimi R, Baer H, Connolly J, Colditz G, Schnitt S, Collins L. Expression of Estrogen Receptor Beta in Invasive Breast Cancers in Relation to Molecular Phenotype. Mod Pathol. 2008.
  66. Marotti J, Tamimi R, Baer H, Connolly J, Colditz G, Schnitt S, Collins L. Comparison of Estrogen Receptor and Progesterone Receptor Assay Results from Pathology Reports with Results from Centralized Testing: Implications for Population-Based Studies . Mod Pathol. 2008.
  67. Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Alshak NS, Puligandla B, Brodsky GL, Schnitt SJ, Habel LA. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol. 2007 Nov; 20(11):1149-55.
    View in: PubMed
  68. Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007 Nov; 44(11):726-31.
    View in: PubMed
  69. Collins LC, Martyniak A, Kandel MJ, Stadler Z, Masciari S, Harris L, Miron A, Richardson A, Schnitt SJ and Garber JE. Is Basal Cytokeratin (CK) or Epidermal Growth Factor Receptor (EGFR) Expression Predictive of BRCA1 Mutation Status in Women with Triple Negative Breast Cancers? . Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2007.
  70. Hilson JB, Schnitt SJ and Collins LC. Phenotypic Alterations in Ductal Carcinoma in Situ-Associated Myoepithelial Cells: Biological and Diagnostic Implications. Mod Pathol. 2007; 20:36A.
  71. Martyniak A, Kandel MJ, Stadler Z, Masciari S, Harris L, Miron A, Richardson A, Schnitt SJ, Garber JE and Collins LC. Is Basal Cytokeratin (CK) or Epidermal Growth Factor Receptor (EGFR) Expression Predictive of BRCA1 Mutation Status in Women with Triple Negative Breast Cancers? . Mod Pathol. 2007; 20:41A.
  72. Alexander BM, Bryan B, Collins LC, Recht A. Atypical cytology in a persistent seroma following mastectomy for breast cancer: a case report and review of the literature. Breast J. 2007 Mar-Apr; 13(2):196-9.
    View in: PubMed
  73. Galaburda LS, Tamimi RM, Baer HJ, Dietz AC, Colditz GA, Schnitt SJand Collins LC. Are The Different Molecularly-Defined Subtypes Of Invasive Breast Cancer Associated With Different Reproductive Risk Factors?. Mod Pathol. 2007; 20:31A.
  74. Galan MA,Tamimi RM, Baer HJ, Deitz AC, Colditz GA, Schnitt SJ and Collins LC. Comparison of the Prevalence of Molecular Phenotypes in DCIS and Invasive Breast Cancer: A Tissue Microarray-Based Analysis of 977 Cases. Mod Pathol. 2007; 20:31A.
  75. Zhu T, Guo J, Collins L, Kelly J, Xiao ZJ, Kim SH, Chen CY. Phellinus linteus activates different pathways to induce apoptosis in prostate cancer cells. Br J Cancer. 2007 Feb 26; 96(4):583-90.
    View in: PubMed
  76. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer. 2007 Jan 15; 109(2):180-7.
    View in: PubMed
  77. Collins L, Schnitt SJ, Colditz GA, Dietz A, Baer HJ, Connolly JL, Rubin M, Fu Y, Rosner B, Tamimi RM. Risk Factors for Luminal, HER2, and Basal-like Breast Cancer Sub-types: Results from a Tissue Microarray-Based Analysis of 3167 Breast Cancers from Women Enrolled in the Nurses’ Health Study. San Antonio Breast Cancer Symposium. 2006.
  78. Collins LC, Martyniak A, Kandel MJ, Stadler Z, Masciari S, Harris L, Miron A, Richardson A, Schnitt SJ, Garber JE. Correlation of BRCA 1 Mutation Status with Basal Cytokeratin and Epidermal Growth Factor Receptor Expression in Women with “Triple Negative” Breast Cancers. San Antonio Breast Cancer Symposium. 2006.
  79. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer. 2006 Sep 15; 107(6):1240-7.
    View in: PubMed
  80. Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006 Aug; 30(8):1002-7.
    View in: PubMed
  81. Upalakalin JN, Collins LC, Tawa N, Parangi S. Carcinoid tumors in the breast. Am J Surg. 2006 Jun; 191(6):799-805.
    View in: PubMed
  82. Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006 May; 19(5):617-21.
    View in: PubMed
  83. O'Malley FP, Mohsin SK, Badve S, Bose S, Collins LC, Ennis M, Kleer CG, Pinder SE, Schnitt SJ. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol. 2006 Feb; 19(2):172-9.
    View in: PubMed
  84. Schnitt SJ and Collins LC. Columnar Cell Lesions and Flat Epithelial Atypia of the Breast. Seminars in Diagnostic Pathology. 2006.
  85. Gilmore H, Tamimi R, Baer H, Connolly J, Colditz, Schnitt and Collins L. Immunophenotype of Invasive Breast Cancers in Women with Prior Biopsy-Confirmed Benign Breast Disease: Results from the Nurses’ Health Study. Lab Invest. 2006.
  86. Kandel MJ, Stadler Z, Masciari S, Collins L, Schnitt S, Harris L, Miron A, Richardson A, Garber JE. Prevalence of BRCA1 Mutations in Triple Negative Breast Cancer. ASCO Meeting. 2006.
  87. Habel LA, Achacoso NS, Nekhlyudov L, Haque R, Schnitt S, Collins L, Acton LL, Fletcher S, Quesenberry CP. Declining recurrence rates among DCIS patients treated with breast-conserving surgery in the community setting . San Antonio Breast Cancer Symposium. 2006.
  88. Kraeft S, Collins L, and Schnitt S. The Protease Cathepsin K is Highly Expressed in the Stroma of Human Breast Cancers. Lab Invest. 2006.
  89. Collins L, Baer H, Tamimi R, Connolly J, Colditz G and Schnitt S. Magnitude and Laterality of Breast Cancer Risk in Women with Atypical Hyperplasia of Ductal and Lobular Types. Lab Invest. 2006.
  90. Collins L, Baer H, Tamimi R, Connolly J, Colditz G and Schnitt S. The Effect of a Positive Family History on Breast Cancer Risk in Women with Prior Benign Breast Disease. Lab Invest. 2006.
  91. Hu J, Zhang X, Dong X, Collins L, Sawyer GJ, Fabre JW. A remarkable permeability of canalicular tight junctions might facilitate retrograde, non-viral gene delivery to the liver via the bile duct. Gut. 2005 Oct; 54(10):1473-9.
    View in: PubMed
  92. Collins LC, Schnitt SJ. HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy. Mod Pathol. 2005 May; 18(5):615-20.
    View in: PubMed
  93. Kurian AW, Mills MA, Jaffee M, Sigal BM, Chun NM, Kingham KE, Collins LC, Nowels KW, Plevritis SK, Garber JE, Ford JM, Hartman AR. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1082-9.
    View in: PubMed
  94. Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer. 2005 May 1; 103(9):1778-84.
    View in: PubMed
  95. Collins LC, Botero ML, Schnitt SJ. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol. 2005 Jan; 123(1):16-20.
    View in: PubMed
  96. Collins L, Baer H, Tamimi R, Connolly J, Colditz G, Schnitt S. Influence of Family History on Breast Cancer Risk in Women with Biopsy-Confirmed Benign Breast Disease: Results from the Nurses’ Health Study. Presented at the 2nd Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2005.
  97. Collins L, Rubin M, Schnitt S. Potential Role for Tissue Microarrays for the Study of Biomarker Expression in Benign Breast Disease and Normal Breast Tissue. Presented at the 2nd Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2005.
  98. Collins L, Carlo VP, Hwang H, Barry T, Yaziji H, Gown AM, Schnitt SJ. . Are So-Called “Intracystic” Papillary Carcinomas Of The Breast In Situ Or Invasive Lesions?. Breast Cancer Res Treat. 2005; 94(suppl 1):2023A.
  99. Collins L, Baer H, Tamimi R, Connolly J, Colditz G, Schnitt S. Magnitude and Laterality of Breast Cancer Risk in According to Histological Type of Atypical Hyperplasia: Results from the Nurses’ Health Study. Breast Cancer Res Treat. 2005; 94(suppl 1):27A.
  100. Kraeft S, Collins L, Sneddon J, Brown P, van de Rijn M, Schnitt S. Stromal Cells of Some Pre-Invasive Breast Lesions Exhibit Biological Attributes of Stromal Cells Associated With Breast Cancers. Lab Invest. 2005; 85(suppl 1):38A.
  101. Kraeft S, Collins L, Sneddon J, Brown P, van de Rijn M, Schnitt S. Stromal Cells of Some Pre-Invasive Breast Lesions Exhibit Biological Attributes of Stromal Cells Associated With Breast Cancers. Presented at the 2nd Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2005.
  102. O’ Malley F, Badve S, Bose S, Collins L, Ennis M, Kleer C, Mohsin S, Pinder S, Schnitt S. How Reproducible is the Diagnosis of Flat Epithelial Atypia of the Breast?. Lab Invest. 2005; 85(suppl 1):46A.
  103. Bryan B, Schnitt S, Collins L. Is There a Ductal Carcinoma in Situ (DCIS) Counterpart to Invasive Basal-like Breast Cancers?. Lab Invest. 2005; 85(suppl 1):28A.
  104. Collins L, Baer H, Tamimi R, Connolly J, Colditz G, Schnitt S. Influence of Family History on Breast Cancer Risk in Women with Biopsy-Confirmed Benign Breast Disease: Results from the Nurses’ Health Study. Breast Cancer Res Treat. 2005; 94(suppl 1):6006A.
  105. Collins LC, Schnitt SJ . The Breast. Mills, SE, ed. Histology for Pathologists. 2005.
  106. Collins L, Rubin M, Schnitt S. Potential Role for Tissue Microarrays for the Study of Biomarker Expression in Benign Breast Disease and Normal Breast Tissue. Lab Invest. 2005; 85(suppl 1):30A.
  107. Collins L, Rubin M, Schnitt S. Are Tissue Microarrays Useful For the Study of Preinvasive Breast Lesions?. Breast Cancer Res Treat. 2004; 88(suppl 1):5023A.
  108. Collins LC, Connolly JL, Page DL, Goulart RA, Pisano ED, Fajardo LL, Berg WA, Caudry DJ, McNeil BJ, Schnitt SJ. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol. 2004 Jan; 28(1):126-31.
    View in: PubMed
  109. Zhang X, Collins L, Sawyer GJ, Dong X, Qiu Y, Fabre JW. In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine. Hum Gene Ther. 2001 Dec 10; 12(18):2179-90.
    View in: PubMed
  110. Zhang X, Collins L, Fabre JW. A powerful cooperative interaction between a fusogenic peptide and lipofectamine for the enhancement of receptor-targeted, non-viral gene delivery via integrin receptors. J Gene Med. 2001 Nov-Dec; 3(6):560-8.
    View in: PubMed
  111. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Feidler J, Smith K, Boomsma D, Hulshoff Pol H, Cannon T, Kawashima R, Mazoyer B. A four-dimensional probabilistic atlas of the human brain. J Am Med Inform Assoc. 2001 Sep-Oct; 8(5):401-30.
    View in: PubMed
  112. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29; 356(1412):1293-322.
    View in: PubMed
  113. Patel S, Zhang X, Collins L, Fabre JW. A small, synthetic peptide for gene delivery via the serpin-enzyme complex receptor. J Gene Med. 2001 May-Jun; 3(3):271-9.
    View in: PubMed
  114. Yu J, Wang Y, Soukhova G, Collins LC, Falcone JC. Excitatory lung reflex may stress inspiratory muscle by suppressing expiratory muscle activity. J Appl Physiol. 2001 Mar; 90(3):857-64.
    View in: PubMed
  115. Collins LC, Niloff J, Burke L, Abu-Jawdeh G, Wang H. Relative risk of high grade squamous intraepithelial lesion associated with prior abnormal Pap smears. J Reprod Med. 2001 Feb; 46(2):105-9.
    View in: PubMed
  116. Li J, Collins L, Zhang X, Gustafsson K, Fabre JW. Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):589.
    View in: PubMed
  117. Li JM, Collins L, Zhang X, Gustafsson K, Fabre JW. Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplantation. 2000 Dec 15; 70(11):1616-24.
    View in: PubMed
  118. Collins L, Sawyer GJ, Zhang XH, Gustafsson K, Fabre JW. In vitro investigation of factors important for the delivery of an integrin-targeted nonviral DNA vector in organ transplantation. Transplantation. 2000 Mar 27; 69(6):1168-76.
    View in: PubMed
  119. Jung I, Reeder JE, Cox C, Siddiqui JF, O'Connell MJ, Collins L, Yang Z, Messing EM, Wheeless LL. Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence. J Urol. 1999 Dec; 162(6):1900-3.
    View in: PubMed
  120. Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ. Predictors of local recurrence following excision alone for ductal carcinoma in situ. Cancer. 1999 Jan 15; 85(2):427-31.
    View in: PubMed
  121. Abner AL, Collins L, Peiro G, Recht A, Come S, Shulman LN, Silver B, Nixon A, Harris JR, Schnitt SJ, Connolly JL. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer. 1998 Dec 15; 83(12):2502-8.
    View in: PubMed
  122. Collins LC, Wang HH, Abu-Jawdeh GM. Qualifiers of atypical squamous cells of undetermined significance help in patient management. Mod Pathol. 1996 Jun; 9(6):677-81.
    View in: PubMed
  123. Rudd MA, George D, Johnstone MT, Moore RT, Collins L, Rabbani LE, Loscalzo J. Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy. Circ Res. 1992 Apr; 70(4):829-34.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Collins's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_